UK Clears Cancer Testing Merger On Firm's Financial Woes
The U.K.'s antitrust enforcer on Friday allowed two medical companies that make a cancer diagnosis tool to merge because one of the companies would likely go out of business without the...To view the full article, register now.
Already a subscriber? Click here to view full article